Understanding the underlying factors and mechanisms involved in regulating cell-mediated protection by CD4+ T cells from FRT will contribute to the foundation of information essential for developing therapeutic tools to protect women against gynecological cancers and sexually transmitted infections as they age in the years following menopause. The gene discussed is CD4; the disease is sexually transmitted disease.